- Home
- PFE vs EQNR Comparison
PFE vs EQNR Comparison
Compare PFE & EQNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFE | EQNR |
|---|---|---|
| Founded | 1849 | 1972 |
| Country | United States | Norway |
| Employees | N/A | 24140 |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 80.6B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PFE | EQNR |
|---|---|---|
| Price | $24.10 | $30.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | $29.29 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 32.6M | 3.7M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.55% | 3.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $62,579,000,000.00 | N/A |
| Revenue This Year | N/A | $13.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $50.29 | ★ $14.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.11 | $22.26 |
| 52 Week High | $28.75 | $43.46 |
Technical Indicators
Market Signals| Indicator | PFE | EQNR |
|---|---|---|
| Relative Strength Index (RSI) | 33.34 | 27.02 |
| Support Level | $24.02 | $22.74 |
| Resistance Level | $26.42 | $41.57 |
| Average True Range (ATR) | 0.56 | 0.77 |
| MACD | -0.20 | -0.44 |
| Stochastic Oscillator | 17.25 | 1.84 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About EQNR Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2025 (50% liquids) and ended 2025 with 5.2 billion barrels of proven reserves (45% liquids). Operations also include oil refineries and natural gas processing, marketing, and trading. The renewables portfolio includes offshore and onshore wind and solar, with total power generation of 5.65 TWh in 2025.